公司新闻

20
2024.08
欧洲杯买球發佈2024中期業績報告及最新進展
26
2024.03
欧洲杯买球與榮盛生物就新型佐劑疫苗項目簽署戰略合作協議
20
2024.03
欧洲杯买球發佈2023全年業績報告及最新進展
30
2024.01
新佐劑重組帶狀皰疹疫苗中國I期臨床研究完成首批受試者入組

行業資訊

24
2022.01
行業觀察|3000億市場暗流湧動,誰將成為“疫苗之王”?
21
2021.12
欧洲杯买球:中國疫苗企業創新範本
08
2021.11
欧洲杯买球:領跑疫苗新型佐劑 | 江湖
20
2021.10
行業觀察|壹針難求何時到頭?從國貨之光HPV疫苗說起

學術論文

2023.03.06
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2
2022.05.11
The preliminary safety and immunogenicity results of a randomized, double-blind, placebo-controlled Phase I trial for a recombinant two-component subunit SARS-CoV-2 vaccine ReCOV
2022.02.12
Lyophilized mRNA-lipid nanoparticles vaccine with long-term stability and high antigenicity against SARS-CoV-2
2021.11.09
A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques